uniQure (QURE) Profit After Tax (2016 - 2026)
uniQure's (QURE) quarterly Profit After Tax came in at -$1.7 million in Q1 2026, up 96.19% year-on-year from -$847651.9 in Q1 2025, and up 99.16% quarter-over-quarter from -$198.4 million in Q4 2025.
uniQure (QURE) Profit After Tax (2016 - 2026) Analysis & Trends
uniQure's Profit After Tax history runs 11 years deep, the most recent figure standing at -$1.7 million for Q1 2026.
- On a quarterly basis, Profit After Tax rose 96.19% year-over-year to -$1.7 million in Q1 2026; TTM through Mar 2026 was -$323.5 million, a 89.79% decrease from a year earlier, with the FY2025 full-year figure at -$204.4 million, up 14.68% from the prior year.
- Profit After Tax grew to -$1.7 million in Q1 2026 per QURE's latest filing, from -$198.4 million in the prior quarter.
- Across five years, Profit After Tax topped out at $5.8 million in Q1 2023 and bottomed at -$198.4 million in Q4 2025.
- The 5-year median for Profit After Tax is -$42.8 million (2025), against an average of -$45.2 million.
- Across the five-year window, Profit After Tax jumped 155.47% in 2023 and tumbled 104357.41% in 2024, its largest moves.
- Year by year, Profit After Tax stood at -$92.1 million in 2022, then grew by 25.93% to -$68.2 million in 2023, then fell by 2.81% to -$70.1 million in 2024, then plunged by 183.03% to -$198.4 million in 2025, then surged by 99.16% to -$1.7 million in 2026.
- Per Business Quant, the three latest QURE Profit After Tax figures stand at -$1.7 million (Q1 2026), -$198.4 million (Q4 2025), and -$80.5 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -36.84 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -14.46 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 227.36 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1.03 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -65.60 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 498.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -453.82 Mn |
| 10 | uniQure | 2.42 Bn | 2.42 Bn | 3.34 Mn | -1.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.66 Mn |
| Dec 31, 2025 | -198.45 Mn |
| Sep 30, 2025 | -80.53 Mn |
| Jun 30, 2025 | -42.82 Mn |
| Mar 31, 2025 | -43.64 Mn |
| Dec 31, 2024 | -70.12 Mn |
| Sep 30, 2024 | -378,000.00 |
| Jun 30, 2024 | -56.30 Mn |
| Mar 31, 2024 | -2.49 Mn |
| Dec 31, 2023 | -68.20 Mn |
| Sep 30, 2023 | -6.12 Mn |
| Jun 30, 2023 | 54,000.00 |
| Mar 31, 2023 | 5.80 Mn |
| Dec 31, 2022 | -92.08 Mn |
| Sep 30, 2022 | -73.23 Mn |
| Jun 30, 2022 | -28.32 Mn |
| Mar 31, 2022 | -10.45 Mn |
| Dec 31, 2021 | -2.77 Mn |
| Sep 30, 2021 | -13.29 Mn |
| Jun 30, 2021 | 392.53 Mn |